OOIR: Observatory of International Research

Papers

(The H4-Index of Digestive and Liver Disease is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial	89
From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies	73
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis	71
Systemic inflammation as fuel for acute liver injury in COVID-19	63
COVID 19 and liver: An A–Z literature review	62
Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis	61
Foreign body and caustic ingestions in children: A clinical practice guideline	57
Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review	55
Furin inhibits epithelial cell injury and alleviates experimental colitis by activating the Nrf2-Gpx4 signaling pathway	50
Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map	49
Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD	48
Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population	45
Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function	43
Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey	42
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging	42
COVID-19 and intestinal inflammation: Role of fecal calprotectin	41
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease	41
Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis	39
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part II: Treatment	39
Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis	37
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED)	36
Gastritis: The clinico-pathological spectrum	36
COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data	34
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis	34
Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection	33

Italian guidelines for the management of irritable bowel syndrome	31
Endoscopic ultrasound-guided gastro-enteric anastomosis: A systematic review and meta-analysis	30
Update on gastroenteropancreatic neuroendocrine tumors	30
Seronegative autoimmune atrophic gastritis is more common in elderly patients	29
COVID-19 in IBD: The experience of a single tertiary IBD center	29